Nachrichten zur Amicus Therapeutics Aktie

Insiderhandel: Chief Legal Officer verkauft Aktien von Amicus Therapeutics im Wert von 111.272$

Rosenberg, Ellen - Vorstand - Tag der Transaktion: 2022-06-21...…

Insiderhandel: Chief Operating Officer verkauft Aktien von Amicus Therapeutics im Wert von 164.100$

Campbell, Bradley L. - Vorstand - Tag der Transaktion: 2022-06-21...…

Short Volatility Alert: Amicus Therapeutics, Inc.

On Tuesday, shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD) experienced volatile short activity. After the activity, the stock price went…

Hicks Thomas Files Brief in Support of the U.S. Chamber of Commerce to Overturn Gulf Oil Lease Ruling

District judges ruling vacated the largest offshore oil and gas lease sale in U.S. history HOUSTON, June 20, 2022 /PRNewswire/…

Insiderhandel: Chairman & CEO verkauft Aktien von Amicus Therapeutics im Wert von 83.839$

Crowley, John F. - Vorstand - Tag der Transaktion: 2022-06-15...…

Why Is Amicus Therapeutics (FOLD) Up 25.1% Since Last Earnings Report?

Amicus Therapeutics (FOLD) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Insiderhandel: Chairman & CEO verkauft Aktien von Amicus Therapeutics im Wert von 90.768$

Crowley, John F. - Vorstand - Tag der Transaktion: 2022-06-03...…

Texas Supreme Court Rules against Data Bank Tyranny, as Urged by the Association of American Physicians and Surgeons (AAPS)

TUCSON, Ariz., June 7, 2022 /PRNewswire/ -- In an 8-to-1 decision, the Texas Supreme Court agreed with the amicus brief…

Form 8-K AMICUS THERAPEUTICS, For: May 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amicus (FOLD) Q1 Earnings Miss, Galafold Sales Top Estimates

Amicus Therapeutics (FOLD) posts a wider-than-expected loss for the first quarter. FOLDs sole marketed drug Galafolds solid sales drive the…

Why Amicus (FOLD) Might Surprise This Earnings Season

Amicus (FOLD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…

Amicus gets US patent related to Fabry disease drug Galafold

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amicus: July 29 PDUFA Makes It A Hold

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Chief Legal Officer verkauft Aktien von Amicus Therapeutics im Wert von 99.797$

Rosenberg, Ellen - Vorstand - Tag der Transaktion: 2022-04-07...…

Insiderhandel: Chief Operating Officer verkauft Aktien von Amicus Therapeutics im Wert von 109.426$

Campbell, Bradley L. - Vorstand - Tag der Transaktion: 2022-03-18...…

Association of American Physicians and Surgeons (AAPS) Files an Amicus Brief in United Airlines Case Against the Covid Vaccine Mandate

TUCSON, Ariz., March 18, 2022 /PRNewswire/ -- On Thursday the Association of American Physicians and Surgeons (AAPS) filed its amicus…

Amicus Therapeutics reports positive long term data of AT-GAA for Pompe disease

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

TEA and American Benefits Council Jointly File Amicus Brief In Support of Arbitration Agreement

WASHINGTON, March 14, 2022 /PRNewswire/ -- The ESOP Association and American Benefits Council jointly filed an amicus brief in the…

Amicus Therapeutics Announces Presentation and Posters at the 2022 MDA Clinical & Scientific Conference

PHILADELPHIA, March 10, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced one oral presentation and two…

High Court Hearing Critical EPA Case Today, States Doctors for Disaster Preparedness

TUCSON, Ariz., Feb. 28, 2022 /PRNewswire/ -- The U.S. Supreme Court is hearing oral arguments today in a case that…

Amicus Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amicus Therapeutics (FOLD) Reports Q4 Loss, Lags Revenue Estimates

Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -107.14% and 0.50%, respectively, for the quarter ended December 2021. Do…

Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall

Amicus Therapeutics Inc (NASDAQ: FOLD) has terminated its plans to spin off its gene therapy assets, citing existing market conditions. read more...…

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company

Heres a roundup of top developments in the biotech space over the last 24 hours: read more...…

Amicus Therapeutics FY 2021 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amicus Therapeutics Earnings Preview

Amicus Therapeutics (NASDAQ:FOLD) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Heres what investors need to…

Amicus Therapeutics Announces Presentations and Posters at the 18th Annual WORLDSymposium™ 2022

PHILADELPHIA, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on…

Insiderhandel: Chairman & CEO verkauft Aktien von Amicus Therapeutics im Wert von 87.610$

Crowley, John F. - Vorstand - Tag der Transaktion: 2022-01-18...…

Amicus Therapeutics (FOLD) Stock Jumps 6.4%: Will It Continue to Soar?

Amicus Therapeutics (FOLD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions…

Amicus Therapeutics (FOLD) Presents At J.P. Morgan 40th Annual Healthcare Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AAOS Files Amicus Brief in Support of Lawsuit Challenging No Surprises Act Rule

WASHINGTON, Jan. 11, 2022 /PRNewswire/ -- The American Association of Orthopaedic Surgeons (AAOS) joined in filing an amicus brief supporting…

Nails Coalition Files Brief Supporting U.S. Government in Tariff Extension

WASHINGTON, Jan. 11, 2022 /PRNewswire/ -- The American Steel Nail Coalition, which represents the vast majority of U.S. nail manufacturers,…

Winston & Strawn Represents More Than 50 Equality Advocates in Amicus Brief Calling for Publication of Equal Rights Amendment

CHICAGO, Jan. 10, 2022 /PRNewswire/ -- Winston & Strawn filed an amicus brief today in the U.S. Court of Appeals…

Amicus Therapeutics falls after announcing preliminary revenue for 2021

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Chairman & CEO verkauft Aktien von Amicus Therapeutics im Wert von 774.119$

Crowley, John F. - Vorstand - Tag der Transaktion: 2022-01-05...…

Amicus Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

PHILADELPHIA, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will present at…

U.S. judiciary panel expresses support for amicus brief financial disclosures

...By Nate Raymond (Reuters) - Members of a federal judiciary panel......…

Insiderhandel: Chief Operating Officer verkauft Aktien von Amicus Therapeutics im Wert von 35.096$

Campbell, Bradley L. - Vorstand - Tag der Transaktion: 2021-12-22...…

Doctors for Disaster Preparedness Files an Amicus Brief against EPA Overreach

TUCSON, Ariz., Dec. 23, 2021 /PRNewswire/ -- On Dec 20, Doctors for Disaster Preparedness filed an amicus brief with the…

EDPMA Files Amicus Brief, Supports Patient Protections

WASHINGTON, Dec. 20, 2021 /PRNewswire/ -- The Emergency Department Practice Management Association (EDPMA), an organization representing the practice of Emergency…

Ingalls & Snyder Works with Fintech Amicus.io to Offer Managed Donor-Advised Fund Accounts

CHARLOTTE, N.C., Dec. 15, 2021 /PRNewswire/ -- Amicus.io, the fintech company with a vision for a more generous world, today…

Amicus (FOLD) Filings for AT-GAA in Pompe Disease Accepted by EMA

The European Medicines Agency accepts Amicus Therapeutics (FOLD) MAA for AT-GAA, a potential treatment for Pompe disease....…

European Medicines Agency Validates Amicus Therapeutics Marketing Authorization Applications for AT-GAA for the Treatment of Pompe Disease

PHILADELPHIA, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the European Medicines Agency…